ViscoTec Pumpen- u. Dosiertechnik GmbH has launched a medical grade sequence of its vipro-HEAD 3D print heads.
The corporate says the brand new sequence has been tailor-made for the necessities of the medical and medical know-how market.
ViscoTec says the print heads are appropriate for functions the place security, materials compatibility and patient-specific care are essential, with product contacting parts being made from both stainless-steel or elastomers and plastics that carry FDA certification. An autoclavable model that may be sterilised at as much as 121 °C has additionally been made out there.
The corporate has confirmed that its vipro-HEAD 3, vipro-HEAD 5, vipro-HEAD 5/5 for 2-component functions, and vipro-HEAD 5 with heating operate (commonplace model as much as 70°C and high-temperature model as much as 110°C) have all been tailored or additional developed as a part of the medical grade sequence.
With these changes, hydrogels, silicones, polycaprolactones, and ceramics can all be processed, opening up potential functions in patient-specific implants, prototyping and progressive remedy options. Particularly, ViscoTec outlines absorbable implants, resembling bone or breast implants; versatile implants, resembling silicone vascular buildings; and 3D printed tablets for individualised drug launch as potential functions.
In Lyon, France, 3Deus Dynamics is utilizing ViscoTec print heads to produce extremely life like anatomical fashions – resembling aortas – for surgical coaching and surgical planning, whereas Healshape us utilizing the print heads to manufacture hydrogel-based, resorbable breast implants which might be customised for every affected person and regenerate after implantation by the physique’s personal tissue.
“With the medical grade sequence of our vipro-HEAD printheads, we’re taking the subsequent step in the direction of additive manufacturing in medical know-how,” explains Johanna Bruckhuber, Enterprise Growth Supervisor Parts & Gadgets at ViscoTec. “This allows our prospects to implement patient-specific options – from implants to individualised medicines – and thus makes an essential contribution to the drugs of the longer term.”
